Connection

Giuseppe Curigliano to Immunotherapy

Back to Details
This is a "connection" page, showing publications Giuseppe Curigliano has written about Immunotherapy.
Giuseppe Curigliano
Connection Strength
0.655
Immunotherapy
  1. The evolving landscape of 'next-generation' immune checkpoint inhibitors: A review. Eur J Cancer. 2019 08; 117:14-31.
    View in: PubMed
    Score: 0.295
  2. Preclinical models of breast cancer: Two-way shuttles for immune checkpoint inhibitors from and to patient bedside. Eur J Cancer. 2019 11; 122:22-41.
    View in: PubMed
    Score: 0.075
  3. Peptide vaccines in early breast cancer. Breast. 2019 Apr; 44:128-134.
    View in: PubMed
    Score: 0.072
  4. Gyneco-oncological genomics and emerging biomarkers for cancer treatment with immune-checkpoint inhibitors. Semin Cancer Biol. 2018 10; 52(Pt 2):253-258.
    View in: PubMed
    Score: 0.068
  5. Entinostat for the treatment of breast cancer. Expert Opin Investig Drugs. 2017 Aug; 26(8):965-971.
    View in: PubMed
    Score: 0.065
  6. Mismatch Repair Deficiency as a Predictive Biomarker for Immunotherapy Efficacy. Biomed Res Int. 2017; 2017:4719194.
    View in: PubMed
    Score: 0.064
  7. Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I study. Breast Cancer Res Treat. 2017 04; 162(3):479-488.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.